These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22393166)

  • 1. Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.
    Reitz C; Conrad C; Roszkowski K; Rogers RS; Mayeux R
    Arch Neurol; 2012 Jul; 69(7):894-900. PubMed ID: 22393166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese.
    Wang J; Yu JT; Jiang T; Tan MS; Wang HF; Tan L; Hu N; Sun L; Zhang W; Tan L
    Exp Gerontol; 2014 Apr; 52():18-22. PubMed ID: 24463050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).
    Lincoln S; Allen M; Cox CL; Walker LP; Malphrus K; Qiu Y; Nguyen T; Rowley C; Kouri N; Crook J; Pankratz VS; Younkin S; Younkin L; Carrasquillo M; Zou F; Abdul-Hay SO; Springer W; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Lewis JM; Dickson D; Graff-Radford NR; Petersen RC; Eckman E; Younkin SG; Ertekin-Taner N
    PLoS One; 2013; 8(6):e64164. PubMed ID: 23750206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.
    Athan ES; Williamson J; Ciappa A; Santana V; Romas SN; Lee JH; Rondon H; Lantigua RA; Medrano M; Torres M; Arawaka S; Rogaeva E; Song YQ; Sato C; Kawarai T; Fafel KC; Boss MA; Seltzer WK; Stern Y; St George-Hyslop P; Tycko B; Mayeux R
    JAMA; 2001 Nov; 286(18):2257-63. PubMed ID: 11710891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).
    Reitz C; Tosto G; Vardarajan B; Rogaeva E; Ghani M; Rogers RS; Conrad C; Haines JL; Pericak-Vance MA; Fallin MD; Foroud T; Farrer LA; Schellenberg GD; George-Hyslop PS; Mayeux R;
    Transl Psychiatry; 2013 May; 3(5):e256. PubMed ID: 23673467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.
    Edwards TL; Pericak-Vance M; Gilbert JR; Haines JL; Martin ER; Ritchie MD
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jul; 150B(5):721-35. PubMed ID: 19105203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.
    White CC; Yang HS; Yu L; Chibnik LB; Dawe RJ; Yang J; Klein HU; Felsky D; Ramos-Miguel A; Arfanakis K; Honer WG; Sperling RA; Schneider JA; Bennett DA; De Jager PL
    PLoS Med; 2017 Apr; 14(4):e1002287. PubMed ID: 28441426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of small ubiquitin-related modifier genes are associated with risk of Alzheimer's disease in Korean: A case-control study.
    Mun MJ; Kim JH; Choi JY; Kim MS; Jang WC; Lee JJ; Eun YL; Kwak SJ; Kim KW; Lee SB
    J Neurol Sci; 2016 May; 364():122-7. PubMed ID: 27084229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRTM3 is dispensable for amyloid-β production in mice.
    Laakso T; Muggalla P; Kysenius K; Laurén J; Paatero A; Huttunen HJ; Airaksinen MS
    J Alzheimers Dis; 2012; 31(4):759-64. PubMed ID: 22710909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
    Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM;
    Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.
    Jun G; Asai H; Zeldich E; Drapeau E; Chen C; Chung J; Park JH; Kim S; Haroutunian V; Foroud T; Kuwano R; Haines JL; Pericak-Vance MA; Schellenberg GD; Lunetta KL; Kim JW; Buxbaum JD; Mayeux R; Ikezu T; Abraham CR; Farrer LA
    Ann Neurol; 2014 Sep; 76(3):379-92. PubMed ID: 25043464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism.
    Zhou Q; Luo L; Wang X; Li X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30914454
    [No Abstract]   [Full Text] [Related]  

  • 14. Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.
    Lee JH; Cheng R; Rogaeva E; Meng Y; Stern Y; Santana V; Lantigua R; Medrano M; Jimenez-Velazquez IZ; Farrer LA; St George-Hyslop P; Mayeux R
    Neurogenetics; 2008 May; 9(2):127-38. PubMed ID: 18340469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
    Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
    J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals.
    Shang Z; Lv H; Zhang M; Duan L; Wang S; Li J; Liu G; Ruijie Z; Jiang Y
    Oncotarget; 2015 Dec; 6(40):42504-14. PubMed ID: 26621834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM10 expression and promoter haplotype in Alzheimer's disease.
    Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
    Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association of SORL1 SNPs with Alzheimer's disease.
    Minster RL; DeKosky ST; Kamboh MI
    Neurosci Lett; 2008 Aug; 440(2):190-2. PubMed ID: 18562096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
    Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
    Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.